Addressing Recurrent C. Difficile Infections in IBD: Advancements, Ongoing Challenges, and the Future of Live Biotherapeutic Products

Addressing Recurrent C. Difficile Infections in IBD: Advancements, Ongoing Challenges, and the Future of Live Biotherapeutic Products

Summarize the burden and pathophysiology of rCDI in the context of IBD Evaluate the latest clinical data and treatment implications associated with newer therapeutic options for rCDI, including recently approved LBPs Implement practical strategies to improve the recognition and optimal management of rCDI in patients with IBD

  • Provider:HMP Education
  • Activity Link: https://hmpeducation.com
  • Start Date: 2025-01-11 06:00:00
  • End Date: 2025-01-11 06:00:00
  • Credit Details: AAPA Category 1 Credit™️: 0.75 hours
    AMA PRA Category 1 Credit™️: 0.75 hours
    Nursing: 0.75 hours
    Pharmacy: 0.75 hours
  • MOC Credit Details: ABS - 0.75 Point; Credit Type(s): Accredited CME (ABS)
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Variable
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Limited
  • Specialty: General Surgery
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.